Literature DB >> 20632268

Association of visceral adiposity with oesophageal and junctional adenocarcinomas.

P Beddy1, J Howard, C McMahon, M Knox, C de Blacam, N Ravi, J V Reynolds, M T Keogan.   

Abstract

BACKGROUND: Obesity is associated with an increased incidence of oesophageal and oesophagogastric junction adenocarcinoma, in particular Siewert types I and II. This study compared abdominal fat composition in patients with oesophageal/junctional adenocarcinoma with that in patients with oesophageal squamous cell carcinoma and gastric adenocarcinoma, and in controls.
METHOD: In total, 194 patients (110 with oesophageal/junctional adenocarcinoma, 38 with gastric adenocarcinoma and 46 with oesophageal squamous cell carcinoma) and 90 matched control subjects were recruited. The abdominal fat area was assessed using computed tomography (CT), and the total fat area (TFA), visceral fat area (VFA) and subcutaneous fat area (SFA) were calculated.
RESULTS: Patients with oesophageal/junctional adenocarcinoma had significantly higher TFA and VFA values compared with controls (both P < 0.001), patients with gastric adenocarcinoma (P = 0.013 and P = 0.006 respectively) and patients with oesophageal squamous cell carcinoma (both P < 0.001). For junctional tumours, the highest TFA and VFA values were seen in patients with Siewert type I tumours (respectively P = 0.041 and P = 0.033 versus type III; P = 0.332 and P = 0.152 versus type II).
CONCLUSION: Patients with oesophageal/junctional adenocarcinoma, in particular oesophageal and Siewert type I junctional tumours, have greater CT-defined visceral adiposity than patients with gastric adenocarcinoma or oesophageal squamous cell carcinoma, or controls. Copyright (c) 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20632268     DOI: 10.1002/bjs.7100

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  26 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  Visceral Adiposity is a Risk Factor for Poor Prognosis in Colorectal Cancer Patients Receiving Adjuvant Chemotherapy.

Authors:  Chun Seng Lee; David J Murphy; Colm McMahon; Blathnaid Nolan; Garret Cullen; Hugh Mulcahy; Kieran Sheahan; Elizabeth Barnes; David Fennelly; Elizabeth J Ryan; Glen A Doherty
Journal:  J Gastrointest Cancer       Date:  2015-09

Review 3.  Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Anamay N Sharma; Mohammad Hassan Murad; Navtej S Buttar; Hashem B El-Serag; David A Katzka; Prasad G Iyer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-22       Impact factor: 11.382

Review 4.  Does Nonalcoholic Fatty Liver Disease Increase the Risk for Extrahepatic Malignancies?

Authors:  Somaya Albhaisi; Arun J Sanyal
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

5.  Gastric cardia cancer: how much is it from fat?

Authors:  Preetika Sinh; Prateek Sharma
Journal:  Dig Dis Sci       Date:  2012-10       Impact factor: 3.199

6.  Distribution of body fat and its influence on esophageal inflammation and dysplasia in patients with Barrett's esophagus.

Authors:  Eric M Nelsen; Yujiro Kirihara; Naoki Takahashi; Qian Shi; Jason T Lewis; Vikneswaran Namasivayam; Navtej S Buttar; Kelly T Dunagan; Ganapathy A Prasad
Journal:  Clin Gastroenterol Hepatol       Date:  2012-03-17       Impact factor: 11.382

7.  Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma.

Authors:  Roy Mano; A Ari Hakimi; Emily C Zabor; Marta A Bury; Olivio F Donati; Christoph A Karlo; Wassim M Bazzi; Helena Furberg; Paul Russo
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

8.  Association of sporadic and familial Barrett's esophagus with breast cancer.

Authors:  M Q Chan; A E Blum; A K Chandar; A M L Kieber Emmons; Y Shindo; W Brock; G W Falk; M I Canto; J S Wang; P G Iyer; N J Shaheen; W M Grady; J A Abrams; P N Thota; K K Guda; A Chak
Journal:  Dis Esophagus       Date:  2018-04-01       Impact factor: 3.429

Review 9.  Influence of obesity on the risk of esophageal disorders.

Authors:  Jesper Lagergren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06       Impact factor: 46.802

10.  Computed tomography-quantified body composition predicts short-term outcomes after gastrectomy in gastric cancer.

Authors:  Y Zhang; J P Wang; X L Wang; H Tian; T T Gao; L M Tang; F Tian; J W Wang; H J Zheng; L Zhang; X J Gao; G L Li; X Y Wang
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.